{"id":"NCT03796676","sponsor":"Pfizer","briefTitle":"JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis","officialTitle":"A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY AND SAFETY OF PF-04965842 CO-ADMINISTERED WITH BACKGROUND MEDICATED TOPICAL THERAPY IN ADOLESCENT PARTICIPANTS 12 TO <18 YEARS OF AGE WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-02-18","primaryCompletion":"2020-04-08","completion":"2020-04-08","firstPosted":"2019-01-08","resultsPosted":"2021-06-04","lastUpdate":"2022-04-13"},"enrollment":287,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Atopic Dermatitis"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"PF-04965842","otherNames":[]},{"type":"DRUG","name":"PF04965842","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"PF-04965842 100 mg QD","type":"EXPERIMENTAL"},{"label":"PF-04965842 200 mg QD","type":"EXPERIMENTAL"}],"summary":"This is a randomized, double blind, placebo controlled, parallel group, Phase 3 study to evaluate the efficacy and safety of PF 04965842 in adolescent participants 12 to \\<18 years of age with moderate to severe AD.","primaryOutcome":{"measure":"Percentage of Participants Achieving Investigator's Global Assessment (IGA) Response of 'Clear' (0) or 'Almost Clear' (1) and â‰¥2 Points Improvement From Baseline at Week 12","timeFrame":"Baseline to Week 12","effectByArm":[{"arm":"Placebo","deltaMin":24.5,"sd":null},{"arm":"PF-04965842 100mg QD","deltaMin":41.6,"sd":null},{"arm":"PF-04965842 200mg QD","deltaMin":46.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0147"},{"comp":"OG000 vs OG002","p":"0.0030"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":6},"locations":{"siteCount":136,"countries":["United States","Australia","China","Czechia","Germany","Hungary","Italy","Japan","Latvia","Mexico","Poland","Spain","Taiwan","United Kingdom"]},"refs":{"pmids":["40028832","38896380","34743361","34406366"],"seeAlso":["https://pmiform.com/clinical-trial-info-request?StudyID=B7451036"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":96},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Nausea","Headache","Pharyngitis"]}}